Supplement

See all supplements

Lung Cancer

Vol. 513 No. 7517_supp ppS1-S48
  • In this Supplement

  • Lung cancer is the mortality king of malignancy, killing 1.6 million people yearly, with a five-year survival rate under 20%. With such grim statistics in mind, researchers are examining the causes of lung cancer with the aim of creating better treatments or even preventing it.

    Cover Art: Russell Cobb

Outlook

Top

Collection

Top
  • Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

    • Yufei Wang
    • James D McKay
    • Thorunn Rafnar
    • Zhaoming Wang
    • Maria N Timofeeva
    • Peter Broderick
    • Xuchen Zong
    • Marina Laplana
    • Yongyue Wei
    • Younghun Han
    • Amy Lloyd
    • Manon Delahaye-Sourdeix
    • Daniel Chubb
    • Valerie Gaborieau
    • William Wheeler
    • Nilanjan Chatterjee
    • Gudmar Thorleifsson
    • Patrick Sulem
    • Geoffrey Liu
    • Rudolf Kaaks
    • Marc Henrion
    • Ben Kinnersley
    • Maxime Vallée
    • Florence LeCalvez-Kelm
    • Victoria L Stevens
    • Susan M Gapstur
    • Wei V Chen
    • David Zaridze
    • Neonilia Szeszenia-Dabrowska
    • Jolanta Lissowska
    • Peter Rudnai
    • Eleonora Fabianova
    • Dana Mates
    • Vladimir Bencko
    • Lenka Foretova
    • Vladimir Janout
    • Hans E Krokan
    • Maiken Elvestad Gabrielsen
    • Frank Skorpen
    • Lars Vatten
    • Inger Njølstad
    • Chu Chen
    • Gary Goodman
    • Simone Benhamou
    • Tonu Vooder
    • Kristjan Välk
    • Mari Nelis
    • Andres Metspalu
    • Marcin Lener
    • Jan Lubiński
    • Mattias Johansson
    • Paolo Vineis
    • Antonio Agudo
    • Francoise Clavel-Chapelon
    • H Bas Bueno-de-Mesquita
    • Dimitrios Trichopoulos
    • Kay-Tee Khaw
    • Mikael Johansson
    • Elisabete Weiderpass
    • Anne Tjønneland
    • Elio Riboli
    • Mark Lathrop
    • Ghislaine Scelo
    • Demetrius Albanes
    • Neil E Caporaso
    • Yuanqing Ye
    • Jian Gu
    • Xifeng Wu
    • Margaret R Spitz
    • Hendrik Dienemann
    • Albert Rosenberger
    • Li Su
    • Athena Matakidou
    • Timothy Eisen
    • Kari Stefansson
    • Angela Risch
    • Stephen J Chanock
    • David C Christiani
    • Rayjean J Hung
    • Paul Brennan
    • Maria Teresa Landi
    • Richard S Houlston
    • Christopher I Amos

    Nature Genetics46, 736–741 ()

  • Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

    • Aria Vaishnavi
    • Marzia Capelletti
    • Anh T Le
    • Severine Kako
    • Mohit Butaney
    • Dalia Ercan
    • Sakshi Mahale
    • Kurtis D Davies
    • Dara L Aisner
    • Amanda B Pilling
    • Eamon M Berge
    • Jhingook Kim
    • Hidefumi Sasaki
    • Seung-il Park
    • Gregory Kryukov
    • Levi A Garraway
    • Peter S Hammerman
    • Julia Haas
    • Steven W Andrews
    • Doron Lipson
    • Philip J Stephens
    • Vince A Miller
    • Marileila Varella-Garcia
    • Pasi A Jänne
    • Robert C Doebele

    Nature Medicine19, 1469–1472 ()

more online

Top

Sponsor:

boehringer_ingelheim

cancer_research